Literature DB >> 32810877

Higher prevalence of metabolic disorders in patients with bilateral primary aldosteronism than unilateral primary aldosteronism.

Zhihua Zhang1, Qin Luo1, Tilakezi Tuersun1, Guoliang Wang1, Ting Wu1, Delian Zhang1, Menghui Wang1, Keming Zhou1, Le Sun1, Na Yue1, Nanfang Li1.   

Abstract

OBJECTIVE: Metabolic syndrome (MetS) is a frequent clinical condition in hypertension patients and is more frequently reported in primary aldosteronism (PA). This study is aimed at investigating the prevalence of MetS and its components in the two major types of patients with adrenal venous sampling (AVS)-confirmed unilateral PA and bilateral PA. DESIGN AND PATIENTS: This was a retrospective cross-section study. We analysed metabolic parameters from 169 PA patients subtyped by AVS, including 85 unilateral PA patients and 84 bilateral PA patients, and we also included 169 non-PA patients matched for age and sex.
RESULTS: Patients with unilateral PA had higher concentrations of aldosterone and lower serum potassium than patients with bilateral PA. However, patients with bilateral PA had higher prevalence of MetS (79.8% vs 64.7%, P = .029), obesity (40.5% vs 24.7%, P = .029), dyslipidemia (72.6% vs 55.3%, P = .019) and hyperglycaemia (29.8% vs 16.5%, P = .040) than those with unilateral PA. Meanwhile, bilateral PA had higher BMI (27.55 ± 4.58 vs 25.57 ± 3.28 kg/m2 , P = .001), waist circumference (98.54 ± 11.44 vs 93.32 ± 10.64 cm, P = .003) and fasting plasma glucose (4.98 ± 1.16 vs 4.64 ± 0.93 mmol/L, P = .034). The logistic regression analysis also showed that bilateral PA was associated with the presence of MetS after adjustment for age, sex and duration of hypertension.
CONCLUSIONS: Patients with bilateral PA have a higher prevalence of MetS than those with unilateral PA, despite unilateral PA patients exhibiting higher concentrations of aldosterone and lower serum potassium, suggesting that unilateral PA and bilateral PA may have differing mechanisms of MetS.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  metabolic syndrome; obesity; primary aldosteronism

Year:  2020        PMID: 32810877     DOI: 10.1111/cen.14318

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Higher aldosterone is associated with increased renal impairment risk in patients with hypertension and abnormal glucose metabolism: a longitudinal study.

Authors:  Mengyue Lin; Mulalibieke Heizhati; Lin Gan; Xiaoguang Yao; Qin Luo; Delian Zhang; Suofeiya Abulikemu; Menghui Wang; Guoliang Wang; Wen Jiang; Junli Hu; Nuerguli Maimaiti; Lei Wang; Ting Wu; Le Sun; Na Yue; Yingli Ren; Nanfang Li
Journal:  J Hypertens       Date:  2022-03-01       Impact factor: 4.844

2.  Clinical impacts of endothelium-dependent flow-mediated vasodilation assessment on primary aldosteronism.

Authors:  Daisuke Watanabe; Satoshi Morimoto; Noriko Morishima; Atsuhiro Ichihara
Journal:  Endocr Connect       Date:  2021-06-08       Impact factor: 3.335

3.  Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.

Authors:  Kuan-Ming Chen; Bo-Ching Lee; Po-Ting Chen; Kao-Lang Liu; Kuan-Heng Lin; Chin-Chen Chang; Tung-Hsin Wu; Jia-Sheng Hong; Yen-Hung Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-16       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.